fenclonine has been researched along with Ear Neoplasms in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Ear Neoplasms: Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, GJ | 1 |
| Luscombe, FE | 1 |
1 other study available for fenclonine and Ear Neoplasms
| Article | Year |
|---|---|
Carcinoid metastasis in the middle ear: anaesthetic and surgical management.
Topics: Carcinoid Tumor; Cyproheptadine; Ear Neoplasms; Ear, Middle; Fenclonine; Humans; Ileal Neoplasms; Ke | 1989 |